Multidimensional advancement of neuroproteomics

Expert Review of Proteomics

Volumn 5, Issue 2, 2008, Pages 149-151

  Veenstra, Timothy D ^a   Marcus, Katrin ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROTEOME; THROMBIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; DEMENTIA; DIFFUSE LEWY BODY DISEASE; EDITORIAL; FRONTOTEMPORAL DEMENTIA; HUNTINGTON CHOREA; LIFE EXPECTANCY; NERVOUS SYSTEM; NEUROPROTEOMICS; PARKINSON DISEASE; PERIPHERAL NERVOUS SYSTEM; PROTEOMICS; SCHIZOPHRENIA; SPINAL CORD; STROKE; THROMBOCYTE;

BIOLOGICAL MARKERS; HUMANS; NERVOUS SYSTEM; NERVOUS SYSTEM DISEASES; PROTEOMICS;

EID: 43449130120     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/14789450.5.2.149     Document Type: Editorial

References (4)

1. Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr. Scand. 76, 465-479 (1987).
2. Ferrer I, Santpere G, Arzberger T et al. Brain protein preservation largely depends on the postmortem storage temperature: implications for study of proteins in human neurologic diseases and management of brain banks: a BrainNet Europe study. J. Neuropathol. Exp. Neurol. 66, 35-46 (2007).
3. Lewczuk P, Kornhuber J, Wiltfang J. The German Competence Net Dementias: standard operating procedures for the neurochemical dementia diagnostics. J. Neural Transm. 113, 1075-1080 (2006).
4. Human Proteome Organization brain proteome project www.hbpp.org